obefazimod

DRUG2 trials

Sponsors

Abivax, Abivax S.A.

Conditions

Crohn's diseaseModerately to Severely Active Crohn Disease

Phase 2

Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease

RecruitingNCT06456593

Abivax S.A.Moderately to Severely Active Crohn Disease

Start: 2024-10-30End: 2028-04-01Target: 212Updated: 2026-04-27

A phase 2b, multicenter, double-blind, placebo-controlled, study to evaluate the efficacy, safety, pharmacokinetics, and pharmacodynamics of obefazimod in subjects with moderately to severely active Crohn’s disease

RecruitingCTIS2023-508234-34-00

AbivaxCrohn's disease

Start: 2025-01-27Target: 161Updated: 2025-09-26